Desq Long
Sign in
SEC FORM 4
$12,298.72

FENNEC PHARMACEUTICALS INC. (FENC)

Acquisition (code A) of 2,224 shares at $5.53 per share.

Reporting Person Hackman Jeffrey S. · Officer Title Chief Executive Officer · Transaction Code A

Traded Oct 12, 2026 · Disclosed Oct 13, 2026

Source: SEC Form 4 · 0001926254-26-000018 · filed 2026-10-13 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "FENNEC PHARMACEUTICALS INC. (FENC)." Disclosed 2026-10-13. https://desqlong.com/cards/0001926254-26-000018-1 (retrieved 2026-10-14).